Search

Search Results

• Holistic Treatment of Obesity: The Importance of Integrating Pharmacotherapy, Dietary Therapy, and Physical Activity for Effective and Sustained Weight Loss

  Magdalena Maria Iwaszko, Marcelina Skajewska, Julia Stojko, Wojciech Kwieciński , Oliwia Dziewięcka , Wojciech Ziębka , Bartłomiej Markowski , Damian Szymański, Paweł Iwaszko , WIktoria Biegała

  75186

  2026-09-14
• Efficacy and safety of semaglutide and tirzepatide in the therapy of obesity and type 2 diabetes – current state of knowledge

  Julianna Rozalia Chyl, Łukasz Kowalewski, Oliwia Barbara Gutowska, Weronika Nowak, Wiktoria Magdalena Kostuch, Agata Zimon, Maria Aleksandra Styczyńska, Olga Błażowska-Danielska, Martyna Zielnik, Alicja Jurewicz

  74691

  2026-08-23
• Tirzepatide - a new drug with great potential in controlling glycemia and body weight

  Magdalena Stabrawa , Filip Prusinowski , Maria Teresa Sarata , Aleksandra Kutaj, Tatyana Savitskaya, Ignacy Hatala, Kiryl Savitski

  69364

  2026-03-06
• Tirzepatide and semaglutide in obesity management and their impact on health-related quality of life – a comparative narrative review

  Weronika Kopniak, Sebastian Konopko, Katarzyna Góra, Wiktoria Wasilewska, Blanka Buszta, Inga Kokuszko, Mateusz Markiewicz

  74311

  2026-08-08
• Orforglipron as a Small-Molecule GLP-1 Receptor Agonist: A New Era of Incretin-Based Oral Therapy?

  Małgorzata Blecharczyk, Aleksandra Jakimowicz, Zuzanna Zofia Kamińska, Aleksandra Malcher, Martyna Mrozek, Martyna Pacanowska-Trawnicka, Agnieszka Zielińska, Igor Zydlewski

  72512

  2026-05-30
• Maintaining Fat-Free Mass and Muscle Mass during obesity therapy with Incretin-Mimetic Drugs

  Dariusz Popiela, Karina Urbańska, Łukasz Stojak, Mateusz Grego, Filip Kwiatkowski, Mateusz Baczewski, Katarzyna Grego, Witold Czyż

  57000

  2025-01-07
• Are GLP-1 Analogues a New Solution for the Treatment of NAFLD?

  Maria Sudoł, Katarzyna Dąbek, Michał Ochwat, Martyna Piekarska, Anna Skowronek, Aleksandra Kajtel, Gabriela Mierzwa, Zofia Sudoł

  56304

  2024-12-12
• From GLP-1 Agonism to Triple-Receptor Therapy. Narrative Review of Semaglutide, Tirzepatide, and Retatrutide in Obesity Management.

  Jerzy Darmoń, Joanna Makowska, Karolina Domańska, Natalia Piegza, Anna Sieczka, Maria Windyga, Krzysztof Paweł Darmoń, Aleksandra Papuga, Makary Hejduk

  70772

  2026-04-21
• Objective Exercise Outcomes During GLP-1 Based Therapy: Distinguishing Cardiorespiratory Fitness from Walking Capacity. A Narrative Review

  Julia Nowak, Jakub Grandos, Mateusz Łaszczych, Barbara Bralewska, Julia Wykrota, Mateusz Polak, Jakub Jonakowski, Kacper Kuczyński, Tomasz Nicpoń

  75671

  2026-09-27
• Drugs Used in the Treatment of Obesity – A Systematic Review

  Olga Plinta, Filip Bednarek, Alicja Hojda, Izabela Małajewicz, Natalia Nawrocka, Karolina Oskroba, Małgorzata Pietrzyk, Hanna Rodak, Dawid Stępień

  67976

  2026-02-05
• The Role of Probiotic Therapy in Pediatric MASLD: Pathophysiological and Clinical Perspectives

  Natalia Staszko, Kamila Bała, Małgorzata Bukowska, Jakub Zbroniec

  67785

  2026-01-19
• Synergistic Role of Creatine Monohydrate in Mitigating Skeletal Muscle Wasting and Strength Decline during GLP-1 Receptor Agonist Therapy: A Comperhensive Review

  Aladdin Salama, Shafea Abdulla, Anhelina Kaminskaya, Sofiia Ivanchuk, Tetiana Savchak, Aleksandra Kurek, Dominika Domińczak, Patryk Górecki, Aleksandra Głowacka, Hubert Feretycki

  70226

  2026-04-04
• GLP-1 receptor agonists and skeletal muscle: The risk of sarcopenic obesity and the role of resistance training. A narrative review

  Roksana Milaniuk, Aleksandra Drzewiecka, Szymon Daniszewski, Izabela Czerny, Beata Surówka, Wioleta Pluta, Krzysztof Talarowski, Piotr Tylec, Arkadiusz Ściubak, Jakub Bryl, Aleksandra Pacek

  74557

  2026-08-17
• Use of GLP-1 receptor agonists and dual agonists in patients with inflammatory bowel disease

  Michał Antoni Dróżdż, Maria Marcak, Weronika Nowicka, Anna Kożuch, Emilia Rymarczyk

  76265

  2026-10-02
• GLP-1-Based Therapies and Relative Energy Deficiency in Sport Among Physically Active Individuals: Plausible Pathways, Evidence Gaps, and Monitoring Considerations

  Jakub Jonakowski, Jakub Grandos, Julia Nowak, Mateusz Łaszczych, Julia Wykrota, Barbara Bralewska, Mateusz Polak

  75467

  2026-09-28
• An Integrated Approach to Obesity Management: Clinical Synergy Between GLP-1 Receptor Agonists and Sports Medicine. A Narrative Review.

  Julia Kociuba, Zuzanna Kruczek , Martyna Kudła, Agata Krawczyk , Natalia Pawełczak, Dorota Kołkowicz , Paweł Czechowicz, Justyna Czechowicz, Mikołaj Antkiewicz, Aleksandra Arczyńska, Maria Drozd, Paulina Łobaza, Szymon Kurciński, Julia Kurcińska , Gabriela Zając

  71209

  2026-05-10
• Advances in Obesity Treatment: Current Approaches and Future Perspectives

  Wojciech Wiesław Lachór, Monika Barbara Solarz, Julia Piekarska, Justyna Maria Solarz, Jakub Tomasz Wawrzyńców, Weronika Cyrkler, Jakub Robak, Stanisław Telega, Paweł Bollin, Urszula Szymczak

  60060

  2025-04-14
• Efficacy and Safety of Tirzepatide in the Treatment of Obesity: A Review of Current Clinical Trials

  Wojciech Kijowski, Knieszko Fahim, Jakub Franaszek, Nadia Herchi, Martyna Jabrzyk, Patrycja Jarczyńska, Mateusz Klusek, Karolina Michalak, Maciej Przybył

  70307

  2026-04-05